Aduro Biotech
ADRO
#8335
Rank
ยฃ0.17 B
Marketcap
ยฃ11.01
Share price
4.18%
Change (1 day)
N/A
Change (1 year)

Revenue for Aduro Biotech (ADRO)

Revenue in 2020 (TTM): ยฃ22.41 Million

According to Aduro Biotech's latest financial reports the company's current revenue is ยฃ21.08 Million. In 2019 the company made a revenue of ยฃ13.01 Million an increase over the revenue in the year 2018 that were of ยฃ11.37 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aduro Biotech from 2014 to 2020

Annual revenue

Year Revenue Change
2020 (TTM)ยฃ22.41 M72.21%
2019ยฃ13.01 M14.39%
2018ยฃ11.37 M-12.48%
2017ยฃ13 M-65.99%
2016ยฃ38.22 M-30.55%
2015ยฃ55.04 M445.07%
2014ยฃ10.09 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Sarepta Therapeutics
SRPT
ยฃ1.82 B 8,533.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
ยฃ0.55 B 2,540.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
ยฃ63.03 M 198.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
ยฃ0.72 M-96.56%๐Ÿ‡ฉ๐Ÿ‡ช Germany